Skip to content

Post-operative Pulmonary Function After Kidney Surgery Under Two Different Techniques

Evaluation of Post-operative Pulmonary Function After Open Kidney Surgery: Comparison Between Thoracic Epidural and Paravertebral Block

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03885583
Enrollment
50
Registered
2019-03-21
Start date
2019-05-01
Completion date
2022-11-30
Last updated
2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Function

Keywords

kidney surgery, thoracic epidural block, paravertebral block

Brief summary

To assess the respiratory and analgesic effects of continuous thoracic paravertebral block versus thoracic epidural in patients undergoing kidney surgery

Detailed description

Study tools * An Ultrasound machine (Madison X6) with superficial linear and curved probe. * A 19 gauge echogenic needle and Plexolong Cather (PAJUNK, Plexolong Meier nanoline, Geisingen, Germany; 60 mm). * A 17-gauge Tuohy needle and 19 G flex-tip catheter: for thoracic epidural. * Spirometer: (Enraf-Nonius, Model SPIRO 601). * Drugs: isobaric bupivacaine 0.25% (aside from the drugs used in the standard operation theatre). * Computer software: computer generated random tables (for randomization) and SPSS 22 (for data analysis) Thoracic epidural (TEP): A pre-procedural ultrasound examination will be done to first identify the correct targeted thoracic level. To accomplish this, the transducer will be placed in the parasagittal plane approximately 5 cm from midline. The thoracic level will be determined by identifying the 12th rib and counting in a cephalad direction until the targeted level is marked. All epidurals will be performed under all aseptic precautions with a 17-gauge Tuohy needle and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheters will be inserted 4 cm into the epidural space and a suitable test dose will be administered to exclude intravascular or sub-arachnoid injection Bupivacaine 0.25% of 7.5-12 ml volume will be given through the epidural catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain. The block height will be tested using pin prick method. After spirometry testing and diaphragmatic ultrasound, the infusion of TEP will be gradually weaned of and the catheter will be removed under complete aseptic precautions. Thoracic paravertebral block: (TPVB) The Ultrasound-probe will be centered on T7. The sagittal technique at the transverse process, in-plane, will be used. The 19 gauge echogenic needle will be inserted in-plane at the lower border of the transducer and advanced in a cephalad position with real-time ultrasound sonography. Injection of small amounts of fluid (hydro-dissection) will aid in needle tip location. When the needle tip reaches the paravertebral space, 7.5-12 ml Bupivacaine 0.25% will be slowly injected after negative aspiration. The endpoint for a successful block is anterior displacement of the pleura. The catheter will be then inserted through the needle and positioned up to 3 cm from skin entry directing upwards in the paravertebral space then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain.

Interventions

thoracic epidural block with bupivacaine 0.25% will be given in the 8th thoracic space using ultrasound

PROCEDUREparavertebral block

paravertebral block with 0.25 bupivacaine will be given at the level of the incision using ultrasound

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* ASA II, III * elective kidney surgery

Exclusion criteria

* patient refusal * contraindications to neuraxial blocks * pneumonectomy * planed postoperative mechanical ventilatoin

Design outcomes

Primary

MeasureTime frameDescription
vital capacity24 hours after operationmeasured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)
forced vital capacity24 hours after operationmeasured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)
forced expiratory volume in one second24 hours after operationmeasured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Tecnologies)

Secondary

MeasureTime frameDescription
pain score24 hours after operationpain will be assessed using VAS score, it provides a range of scores from 0-100. A higher score indicates greater pain intensity.
diaphragmatic excursion24 hours after operationultrasound assessment of diaphragmatic excursion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026